
    
      The standard treatment of patients with chronic hepatitis C infection (HCV) is treatment with
      ribavirin. Actually, the compliance (2x daily) seems to be a problem. To increase patients'
      compliance, it is investigated if the total dose of ribavirin can be taken once daily.

      The pharmacokinetics of ribavirin at different dosage regimes is investigated.
    
  